- Home
- / ASLAN Pharmaceuticals
ASLAN Pharmaceuticals
Total Funding
$100 M
Revenue
$12 M
FY, 2023
ASLAN Pharmaceuticals Summary
Company Summary
- Overview
- ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
- Type
- Private
- Status
- Active
- HQ
- SG | view all locations
- Website
- http://aslanpharma.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Stephen Doyle, Chief Business Officer
Kenneth Kobayashi, Chief Medical Officer
Ben Goodger, General Counsel
LocationsView all
4 locations detected
Collingwood, Victoria
Australia
58 Gipps St
Shanghai Shi
China
83 Wanhangdu Rd, Jingan Qu
Taipei City
Taiwan
ASLAN Pharmaceuticals Financials
Summary Financials
- Net income (Q1, 2024)
- ($9.9M)
- Cash (Q1, 2024)
- $18.4M
- EBIT (Q1, 2024)
- ($9.3M)